Tender Title: ECHS BOQ01 2025
Reference Number: GEM/2025/B/6166862
The ECHS BOQ01 2025 tender is issued by the Department of Military Affairs, under the Ministry of Defence. This tender invites bids for the supply of various pharmaceutical products, including Bethanechol 25 mg Tablet, Indomethacin 25 mg Capsule, Hydrocortisone 5 mg Tablet, Sevelamer 800 mg Tablet, Alfuzosin, and Inj Trastuzumab Deruxtecan 100 mg.
Scope of Work and Objectives
The primary objective of this tender is to procure a total quantity of 879,693 units of specified medical products. This initiative aims to ensure that the healthcare needs of the armed forces are met with quality medicines in a timely manner. It is crucial that all suppliers adhere to the technical and quality specifications outlined in the tender documents.
Eligibility Criteria
To qualify for this tender, bidders must be registered entities with a valid license to operate in the pharmaceutical sector. Additionally, they must meet all regulatory compliance requirements and possess the necessary certifications to supply healthcare products.
Technical Requirements
Bidders are required to meet certain technical specifications outlined in the tender. This includes adhering to stringent quality standards relevant to pharmaceutical products, such as Good Manufacturing Practices (GMP) and other compliance requirements as mandated by health authorities.
Financial Requirements
Bidders must demonstrate financial stability, with evidence of sufficient working capital to undertake the procurement in question. This includes providing details concerning any Earnest Money Deposit (EMD) needed and outlining the payment terms acceptable by the issuing authority.
Document Submission Details
Interested parties must prepare and submit their documents electronically, adhering strictly to the formats specified in the tender documentation. All submissions should be complete and submitted before the specified deadline to be considered valid.
Special Provisions
This tender encourages bids from Micro, Small, and Medium Enterprises (MSEs), offering them advantages during the evaluation process. Furthermore, startups that are compliant with specific provisions will be given priority consideration as part of the government’s support for new ventures in the pharmaceutical sector.
Evaluation Process
Bids will be subjected to a comprehensive evaluation methodology, which will involve assessment against criteria such as pricing, adherence to specifications, and previous performance records. The price evaluation will consider various components, and the final decision will rest on the overall value for money.
Delivery Locations
Suppliers should be prepared to deliver the products to specified military healthcare facilities across the designated regions as detailed in the tender documents.
Contact Information
For further inquiries regarding this tender, bidders are encouraged to refer to the official channels provided in the tender documentation.
In summary, the ECHS BOQ01 2025 tender represents a significant procurement opportunity in the healthcare domain, aimed at fostering quality healthcare services for armed forces personnel.
Tender BOQ Items
61 ItemsGeneral Information
Financial Information
Evaluation and Technical Information
Tender Documents
5 DocumentsDocuments Required from Seller
- Bidder Turnover
- Certificate (Requested in ATC)
- OEM Authorization Certificate
- OEM Annual Turnover
- Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
- the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Similar Tenders
Frequently Asked Questions
The eligibility requirements include being a registered entity in the pharmaceutical sector, possessing necessary licenses and certifications, and adhering to all relevant regulatory compliance standards. Suppliers must also demonstrate financial stability through adequate capital to undertake the contract.
Bidders must provide all relevant certificates that validate their capability to supply pharmaceuticals. Key certifications include Good Manufacturing Practice (GMP), FDA approval if applicable, and any other certifications pertinent to the quality and safety of the products being supplied.
The registration process involves submitting required documents electronically as outlined in the tender documentation. Participants must ensure compliance with specified formats and criteria, submitting their applications ahead of the deadline to avoid disqualification.
The accepted document formats include PDF, Word, and Excel files, among others as prescribed in the tender documentation. It is vital for bidders to adhere strictly to the specified formats to ensure their submissions are accepted.
The performance security requirements typically involve a financial guarantee presented by the winning bidder to ensure compliance with the contract terms. This may include a bank guarantee or a deposit equivalent to a percentage of the contract value, ensuring that total performance meets the standards outlined in the tender.
Probable Bidders
Get Tender Alerts
Get notifications for similar tenders